Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has disclosed the acquisition of a substantial shareholding, including details of voting power and relevant interests. The total votes attached to the voting shares held by the new substantial holder and their associates are meticulously listed, along with the registered holders of these shares. The consideration for the acquisition, encompassing all benefits and compensations, is also provided, demonstrating the financial transparency of the transaction.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
